Angiotensin II Receptor Antagonists: A New Way to Deal with Stroke Prevention in Hypertension

Author： Tocci Giuliano   Giovannelli Francesca   Facciolo Caterina  

Publisher： Adis International

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.14, Iss.1, 2007-01, pp. : 39-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Comparative Pharmacology of Angiotensin II Receptor Antagonists

By Burnier Michel   Maillard Marc  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 6-11

Informa Healthcare

Access to resources Recommend Favorite

Renal Effects of Angiotensin II Receptor Antagonists

By Burgess Ellen  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 17-20

Informa Healthcare

Access to resources Recommend Favorite

The Role of Angiotensin II Receptor Antagonists in the Management of Diabetes

By Barnett Anthony H.  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 21-26

Informa Healthcare

Access to resources Recommend Favorite

Similarities and Differences between Angiotensin II Type 1 Receptor Antagonists

By Alberto Corsini  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 3, 2004-01 ,pp. : 117-121

Adis International

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite